Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romeo Romagnoli

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Current Topics in Medicinal Chemistry|December 8, 2004
Agonists and antagonists acting at P2X7 receptorPier Giovanni Baraldi, Francesco Di Virgilio, Romeo Romagnoli
Drug Discovery Today. Technologies|September 21, 2013
Allosteric modulation of A1-adenosine receptor: a reviewMaría Kimatrai-Salvador, Pier Giovanni Baraldi, Romeo Romagnoli
Bioorganic & Medicinal Chemistry|May 9, 2003
Benzoyl nitrogen mustard derivatives of benzoheterocyclic analogues of netropsin: synthesis and biological activityPier Giovanni Baraldi, Romeo Romagnoli, Nicoletta Bianchi, et al.
Future Medicinal Chemistry|July 12, 2021
Thio-substituted derivatives of 4-amino-pyrazolo[3,4-d]pyrimidine-6-thiol as antiproliferative agentsBarbara Cacciari, Romeo Romagnoli, Arianna Romani, et al.
Current Drug Targets. Cardiovascular & Haematological Disorders|February 22, 2005
Leukocyte P2 receptors: a novel target for anti-inflammatory and anti-tumor therapyFrancesco Di Virgilio, O Roberto Baricordi, Romeo Romagnoli, et al.
Current Topics in Medicinal Chemistry|February 3, 2004
Distamycin A as stem of DNA minor groove alkylating agentsPier Giovanni Baraldi, Maria del Carmen Nûnez, Antonio Espinosa, et al.
Bioorganic & Medicinal Chemistry|November 4, 2006
Hybrid molecules between distamycin A and active moieties of antitumor agentsPier Giovanni Baraldi, Delia Preti, Francesca Fruttarolo, et al.
Purinergic Signalling|April 30, 2008
Recent improvements in the development of A(2B) adenosine receptor agonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, et al.
International Journal of Oncology|July 19, 2021
Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti‑tubulin tetrahydrothieno[2,3‑c]pyridine derivative and a peptide nucleic acid targeting miR‑221‑3pMatteo Zurlo, Romeo Romagnoli, Paola Oliva, et al.
International Journal of Molecular Sciences|June 10, 2022
Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1<i>H</i>-Imidazole ScaffoldMatteo Zurlo, Romeo Romagnoli, Paola Oliva, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Current Topics in Medicinal Chemistry|December 8, 2004
Agonists and antagonists acting at P2X7 receptorPier Giovanni Baraldi, Francesco Di Virgilio, Romeo Romagnoli
Drug Discovery Today. Technologies|September 21, 2013
Allosteric modulation of A1-adenosine receptor: a reviewMaría Kimatrai-Salvador, Pier Giovanni Baraldi, Romeo Romagnoli
Bioorganic & Medicinal Chemistry|May 9, 2003
Benzoyl nitrogen mustard derivatives of benzoheterocyclic analogues of netropsin: synthesis and biological activityPier Giovanni Baraldi, Romeo Romagnoli, Nicoletta Bianchi, et al.
Future Medicinal Chemistry|July 12, 2021
Thio-substituted derivatives of 4-amino-pyrazolo[3,4-d]pyrimidine-6-thiol as antiproliferative agentsBarbara Cacciari, Romeo Romagnoli, Arianna Romani, et al.
Current Drug Targets. Cardiovascular & Haematological Disorders|February 22, 2005
Leukocyte P2 receptors: a novel target for anti-inflammatory and anti-tumor therapyFrancesco Di Virgilio, O Roberto Baricordi, Romeo Romagnoli, et al.
Current Topics in Medicinal Chemistry|February 3, 2004
Distamycin A as stem of DNA minor groove alkylating agentsPier Giovanni Baraldi, Maria del Carmen Nûnez, Antonio Espinosa, et al.
Bioorganic & Medicinal Chemistry|November 4, 2006
Hybrid molecules between distamycin A and active moieties of antitumor agentsPier Giovanni Baraldi, Delia Preti, Francesca Fruttarolo, et al.
Purinergic Signalling|April 30, 2008
Recent improvements in the development of A(2B) adenosine receptor agonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, et al.
International Journal of Oncology|July 19, 2021
Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti‑tubulin tetrahydrothieno[2,3‑c]pyridine derivative and a peptide nucleic acid targeting miR‑221‑3pMatteo Zurlo, Romeo Romagnoli, Paola Oliva, et al.
International Journal of Molecular Sciences|June 10, 2022
Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1<i>H</i>-Imidazole ScaffoldMatteo Zurlo, Romeo Romagnoli, Paola Oliva, et al.
Pageof 16